Fernando Custodio Fervenza, MD, PhD

  • 13473 Citations
  • 55 Scopus h-Index
1976 …2020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1989 2020

Filter
Letter
2019

Rituximab or Cyclosporine for Membranous Nephropathy. Reply

Fervenza, F. C. & Cattran, D. C., Oct 24 2019, In : The New England journal of medicine. 381, 17, p. 1689-1690 2 p.

Research output: Contribution to journalLetter

Membranous Glomerulonephritis
Immunosuppressive Agents
Cyclosporine
Rituximab
2018

The authors reply

Ravindran, A., Fervenza, F. C., Smith, R. J. H. & Sethi, S. M., Sep 1 2018, In : Kidney International. 94, 3, p. 632-633 2 p.

Research output: Contribution to journalLetter

2017

The Authors Reply

Ravindran, A., Go, R. S., Fervenza, F. C. & Sethi, S. M., Aug 1 2017, In : Kidney International. 92, 2, p. 517 1 p.

Research output: Contribution to journalLetter

2016
5 Citations (Scopus)

C4d as a marker for masked immune deposits

Sethi, S. M., Hernandez, L. H., Alexander, M. P. & Fervenza, F. C., Jul 1 2016, In : Kidney International. 90, 1, p. 223-224 2 p.

Research output: Contribution to journalLetter

Biomarkers
1 Citation (Scopus)

In Reply to ‘C4 Deposition in Glomerular Disease’

Sethi, S. M. & Fervenza, F. C., Nov 1 2016, In : American Journal of Kidney Diseases. 68, 5, p. 817 1 p.

Research output: Contribution to journalLetter